Download PDF
Thromb Haemost 1973; 29(01): 190-195
DOI: 10.1055/s-0038-1647759
Original Article
Schattauer GmbH

Effects “in Vitro” of Some Cardiovascular Drugs and Other Agents on Human Platelet Aggregation

G Sacchetti
1   Medical Department, Clinical Research Division, Carlo Erba, Milano and Centro Trasfusionale e Immuno-Ematologico, Ospedale S. Carlo Borromeo, Milano ( Italy)
,
D Bellani
1   Medical Department, Clinical Research Division, Carlo Erba, Milano and Centro Trasfusionale e Immuno-Ematologico, Ospedale S. Carlo Borromeo, Milano ( Italy)
,
C Montanari
1   Medical Department, Clinical Research Division, Carlo Erba, Milano and Centro Trasfusionale e Immuno-Ematologico, Ospedale S. Carlo Borromeo, Milano ( Italy)
,
A Gibelli
1   Medical Department, Clinical Research Division, Carlo Erba, Milano and Centro Trasfusionale e Immuno-Ematologico, Ospedale S. Carlo Borromeo, Milano ( Italy)
› Author Affiliations
Further Information

Publication History

Received 24 July 1972

Publication Date:
24 July 2018 (online)

    Permissions and Reprints

Summary

The in vitro effect of the following substances on human platelet aggregation is studied: K 4423 (a ß-blocking drug), isoproterenol, phentolamine, papaverine, methamidoline (a myolytic agent).

None of these substances causes aggregation. All inhibit aggregation induced by ADP or noradrenaline, except for phentolamine, which is active only on noradrenaline- induced aggregation.

Hypothesis on the mechanism of action of the compounds tested are proposed.

 

  • References

  • 1 Ahtee L, Michal F. 1972. Effect of sympathomimetic amines on rabbit platelet aggregation in vitro. Proceedings of the British Pharmacological Society. London: 4-6 January 1972, 63.
    Google Scholar
  • 2 Amer M. S. 1969; Mechanism of action of eholecystokinin. Clinical Research 17: 520.
    PubMedGoogle Scholar
  • 3 Born G. V. R, Cross M. J. 1963; The aggregation of blood platelets. Journal of Physiology 168: 178.
    CrossrefPubMedGoogle Scholar
  • 4 Born G. V. R, Mills D. C. B, Roberts G. C. K. 1967; Potentiation of platelet aggregation by adrenaline. The Journal of Physiology 191: 43.
    PubMedGoogle Scholar
  • 5 Bucher H. W, Stucki P. 1969; The effect of various beta-receptor blocking agents on platelet aggregation. Experimentia 25: 280.
    CrossrefPubMedGoogle Scholar
  • 6 Giraldi P. N, Nannini G, Logbmann W, Franceschini J, Passerini N. 1969; Sintesi di 1 - oxo -N - alchil - 3 - amino -f enil -isoindoline. In: “Convegno di Ohimica del Farmaco e dei Prodotti Biologicamente attivi” Rome, (Italy) 15-18 december, 1969. Abstracts 75 1..
    PubMedGoogle Scholar
  • 7 Haslam R. J, Taylor A. 1971; Effects of cathecolamines on the formation of adenosine 3’ : 55-cyclic monophosphate in human blood platelets. Biochemical Journal 125: 377.
    CrossrefPubMedGoogle Scholar
  • 8 Ktjkovetz W. R, Poch G. 1970; Inhibition of cyclic-35, 55-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn-Schmiedebergs Archiv für Pharmakologie und Experimentelle Pathologie 267: 189.
    PubMedGoogle Scholar
  • 9 Lauria F, Vecchietti Y, Rabini T, Tommasini R, Buonamici M, Usardi M. M. Derivatives of 1,4-methano and 1,4-ethano-1,2,3,4-tetrahydronaphthalene as ß-adrenergic blocking agents. (In preparation.)
    PubMedGoogle Scholar
  • 10 Markwardt F, Hoffmann A. 1970; Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets. Biochemical Pharmacology 19: 2519.
    CrossrefPubMedGoogle Scholar
  • 11 Mills D. C. B, Roberts G CK. 1967; Effect of adrenaline on human blood platelets. Journal of Physiology 193: 443.
    CrossrefPubMedGoogle Scholar
  • 12 Moskowitz J, Harwood J. P, Reid W. D. Krishna 1961; The interaction of norepinephrine and prostaglandin Ex on the adenyl cyclase system of human and rabbit blood platelets. Biochimica et Biophisica Acta 230: 279.
    PubMedGoogle Scholar
  • 13 Robison G. A, Butcher R. W, Sutherland E. W. 1970. On the relation of hormone receptors to adenyl cyclase. In: Danielli J. F, Moran J. F, Triggle D. J. (eds.) Fundamental Concepts in Drug-receptor interactions. Academic Press; London: 59.
    Google Scholar
  • 14 Rufeger U, Tellhelm B, Frimmer M. 1971; Inhibition by papaverine of 35,55-nucleotide- phosphodiesterase. (E. C. 3.1.4.1.) from bovine uterus muscle. Naunyn- Schmiedebergs Archiv, für Pharmakologie und Experimentelle Pathologie 270: 428.
    PubMedGoogle Scholar
  • 15 Rysanek K, Svehla C, Spânkova H, Mlejnkovâ M. 1968; Comparison of the effect of various sympathicolytics on thrombocyte aggregation. Journal of Pharmacy and Pharmacology 20: 154.
    CrossrefPubMedGoogle Scholar
  • 16 Smith J. B, Mills D CB. 1970; Inhibition of adenosine 3’ : ö’-cyclic monophosplmte phosphodiesterase. The Biochemical Journal 120: 20.
    PubMedGoogle Scholar